Catalysts for Aspiro Pharma Ltd
9 tracked
Apr 15, 2026
approval
SODIUM BICARBONATE — FDA approval
SODIUM BICARBONATE
→
Mar 17, 2026
approval
MICAFUNGIN SODIUM — FDA approval
MICAFUNGIN SODIUM
→
Mar 4, 2026
approval
ROCURONIUM BROMIDE — FDA approval
ROCURONIUM BROMIDE
→
Nov 13, 2025
approval
VERAPAMIL HYDROCHLORIDE — FDA approval
Calan
→
Oct 29, 2025
recall
Aspiro Pharma Limited recall (Cls II)
Aspiro Pharma Ltd
→
Oct 15, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 15, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 5, 2023
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
May 18, 2022
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→